Amgen reported $9.33B in Equity Capital and Reserves for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 810.83M 44.28M
Agios Pharmaceuticals AGIO:US $ 2296.63M 1897.13M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
ALKERMES ALKS:US $ 1051.16M 15.83M
Amgen AMGN:US $ 9334M 75M
Astrazeneca AZN:US $ 14430M 1192M
Biogen BIIB:US $ 10682.2M 18.1M
Biomarin Pharmaceutical BMRN:US $ 4162.01M 56.01M
Bluebird Bio BLUE:US $ 1200.33M 154.72M
Bristol Myers Squibb BMY:US $ 37605M 217M
Coherus Biosciences CHRS:US $ 127.67M 153.3M
Dicerna Pharmaceuticals DRNA:US $ 126.4M 11.35M
Eli Lilly And LLY:US $ 6898.7M 1257.1M
Exelixis EXEL:US $ 1911.19M 32.07M
Genmab GEN:DC DK 20095M 974M
Gilead Sciences GILD:US $ 18964M 762M
GlaxoSmithKline GSK:LN 14865M 278M
Glaxosmithkline GSK:US $ 14865M 278M
Intercept Pharmaceuticals ICPT:US $ -200M 33.15M
IONIS PHARMACEUT IONS:US $ 680.56M 162.78M
Johnson & Johnson JNJ:US $ 65834M 2556M
Mirati Therapeutics MRTX:US $ 1259.41M 101.38M
Moderna Inc MRNA:US 3.84B 1.28B
Neurocrine Biosciences NBIX:US $ 1205.6M 79.4M
Novartis NOVN:VX SF 50523M 6075M
Novartis NVS:US $ 50523M 6075M
Ptc Therapeutics PTCT:US $ 292.58M 189.41M
Puma Biotechnology PBYI:US $ 16.44M 22.39M
Regeneron Pharmaceuticals REGN:US $ 11977M 951.7M
Sarepta Therapeutics SRPT:US $ 535.45M 226.31M
Seattle Genetics SGEN:US $ 3424.62M 63.48M
Takeda 4502:JP Y 5173037M 537684M
Teva Pharmaceutical TEVA:IT 10B 26M
Ultragenyx Pharmaceutical RARE:US $ 1054.58M 99.79M
Vertex Pharmaceuticals VRTX:US $ 8980.25M 293.44M
YTE INCY:US $ 2727.84M 116.58M